COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00891267
Brief Title: Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome (VAMOS)

First Submitted : April 29, 2009
First Submitted that Met QC Criteria : April 30, 2009
First Posted : May 1, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : December 20, 2018
Last Update Posted : December 24, 2018